114 related articles for article (PubMed ID: 37419331)
21. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
Gu PS; Moon M; Choi JG; Oh MS
J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
[TBL] [Abstract][Full Text] [Related]
22. Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units.
Zou J; Chen Z; Wei X; Chen Z; Fu Y; Yang X; Chen D; Wang R; Jenner P; Lu JH; Li M; Zhang Z; Tang B; Jin K; Wang Q
Cell Death Dis; 2017 Jun; 8(6):e2854. PubMed ID: 28569795
[TBL] [Abstract][Full Text] [Related]
23. Synaptojanin1 deficiency upregulates basal autophagosome formation in astrocytes.
Pan PY; Zhu J; Rizvi A; Zhu X; Tanaka H; Dreyfus CF
J Biol Chem; 2021 Jul; 297(1):100873. PubMed ID: 34126070
[TBL] [Abstract][Full Text] [Related]
24. Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model.
Gan L; Vargas MR; Johnson DA; Johnson JA
J Neurosci; 2012 Dec; 32(49):17775-87. PubMed ID: 23223297
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effects of protocatechuic aldehyde against neurotoxin-induced cellular and animal models of Parkinson's disease.
Zhao X; Zhai S; An MS; Wang YH; Yang YF; Ge HQ; Liu JH; Pu XP
PLoS One; 2013; 8(10):e78220. PubMed ID: 24205164
[TBL] [Abstract][Full Text] [Related]
26. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
[TBL] [Abstract][Full Text] [Related]
27. Gami-Chunggan Formula Prevents Motor Dysfunction in MPTP/p-Induced and A53T α-Synuclein Overexpressed Parkinson's Disease Mouse Model Though DJ-1 and BDNF Expression.
Ahn S; Liu QF; Jang JH; Park J; Jeong HJ; Kim Y; Kim DH; Jeong G; Oh ST; Park SU; Cho SY; Park HJ; Jeon S
Front Aging Neurosci; 2019; 11():230. PubMed ID: 31555122
[TBL] [Abstract][Full Text] [Related]
28. Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-Synuclein in Parkinson's disease rats.
Yu L; Hu X; Xu R; Zhao Y; Xiong L; Ai J; Wang X; Chen X; Ba Y; Xing Z; Guo C; Mi S; Wu X
J Ethnopharmacol; 2024 Mar; 322():117628. PubMed ID: 38158101
[TBL] [Abstract][Full Text] [Related]
29. Decrease in
Han S; Seo MH; Lim S; Yeo S
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884422
[TBL] [Abstract][Full Text] [Related]
30. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
[TBL] [Abstract][Full Text] [Related]
31. Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.
Su C; Yang X; Lou J
Brain Res; 2016 Aug; 1644():98-106. PubMed ID: 27173998
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Potential Neuroprotective Effects of Vanillin Against MPP
Rani L; Ghosh B; Ahmad MH; Mondal AC
Mol Neurobiol; 2023 Aug; 60(8):4693-4715. PubMed ID: 37145378
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein.
Li XZ; Zhang SN; Wang KX; Liu HY; Yang ZM; Liu SM; Lu F
Phytomedicine; 2014 Apr; 21(5):704-11. PubMed ID: 24252343
[TBL] [Abstract][Full Text] [Related]
34. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway.
Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY
Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958
[TBL] [Abstract][Full Text] [Related]
35. Roflupram protects against rotenone-induced neurotoxicity and facilitates α-synuclein degradation in Parkinson's disease models.
Dong WL; Zhong JH; Chen YQ; Xie JF; Qin YY; Xu JP; Cai NB; Li MF; Liu L; Wang HT
Acta Pharmacol Sin; 2021 Dec; 42(12):1991-2003. PubMed ID: 34531546
[TBL] [Abstract][Full Text] [Related]
36. Mutational analysis of SYNJ1 gene (PARK20) in Parkinson's disease in a Taiwanese population.
Chen KH; Wu RM; Lin HI; Tai CH; Lin CH
Neurobiol Aging; 2015 Oct; 36(10):2905.e7-8. PubMed ID: 26149920
[TBL] [Abstract][Full Text] [Related]
37. Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice.
Haga H; Yamada R; Izumi H; Shinoda Y; Kawahata I; Miyachi H; Fukunaga K
Pharmacol Biochem Behav; 2020 Apr; 191():172891. PubMed ID: 32126223
[TBL] [Abstract][Full Text] [Related]
38. GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson's Disease.
Schneider JS; Aras R; Williams CK; Koprich JB; Brotchie JM; Singh V
Sci Rep; 2019 Jun; 9(1):8362. PubMed ID: 31182727
[TBL] [Abstract][Full Text] [Related]
39. The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson's Disease.
Deng I; Garg S; Zhou XF; Bobrovskaya L
Front Biosci (Schol Ed); 2022 May; 14(2):13. PubMed ID: 35730438
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting α-synuclein expression in MPTP-induced Parkinson's disease mouse.
Wang ZH; Zhang JL; Duan YL; Zhang QS; Li GF; Zheng DL
Biomed Pharmacother; 2015 Aug; 74():252-6. PubMed ID: 26349993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
